BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh Bhinder N, Zangan SM. Hepatocellular carcinoma rupture following transarterial chemoembolization. Semin Intervent Radiol 2015;32:49-53. [PMID: 25762848 DOI: 10.1055/s-0034-1396964] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Nishi M, Saeki I, Yamasaki T, Maeda M, Hisanaga T, Iwamoto T, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Sakaida I. Hemobilia immediately after transcatheter arterial chemoembolization using drug-eluting beads for hepatocellular carcinoma with intrahepatic bile duct invasion. Hepatol Res 2018;48:329-32. [PMID: 29098752 DOI: 10.1111/hepr.12995] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Moon HH, Chu HH, Shin JH. Rupture of hepatocellular carcinoma after transcatheter arterial chemoembolization: A case report. Int J Gastrointest Interv 2021;10:32-5. [DOI: 10.18528/ijgii200028] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kalisz K, Enzerra M, Mansoori B. Overview of spontaneous intraabdominal tumor hemorrhage: etiologies, imaging findings, and management. Abdom Radiol (NY) 2021;46:427-40. [PMID: 32691111 DOI: 10.1007/s00261-020-02663-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nishida K, Lefor AK, Funabiki T. Rupture of Hepatocellular Carcinoma after Transarterial Chemoembolization followed by Massive Gastric Bleeding. Case Reports Hepatol 2018;2018:4576276. [PMID: 29974003 DOI: 10.1155/2018/4576276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Terasawa M, Allard MA, Golse N, Sa Cunha A, Cherqui D, Adam R, Saiura A, Vibert E. Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization alone before major hepatectomy for patients with large hepatocellular carcinoma: An intent-to-treat analysis. Surgery 2020;167:425-31. [PMID: 31780050 DOI: 10.1016/j.surg.2019.09.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Thomas AJ, Menias CO, Pickhardt PJ, Shaaban AM, Gaballah AH, Yedururi S, Elsayes KM. Bleeding Liver Masses: Imaging Features With Pathologic Correlation and Impact on Management. AJR Am J Roentgenol 2019;213:8-16. [PMID: 30973778 DOI: 10.2214/AJR.19.21240] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Smith JC, Nasiri A, Fujimoto S, Volk M. Ruptured Hepatocellular Carcinoma following Transarterial Radioembolization. J Vasc Interv Radiol 2018;29:1302-5. [PMID: 30146205 DOI: 10.1016/j.jvir.2018.04.017] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Zhu LB, Li TF, Li JQ, Li PF, Zhang PB, Wu HB, Xv R. Diffuse biliary peritonitis secondary to rupture of metastatic liver adenocarcinomas after drug-eluting bead transcatheter arterial chemoembolization: a case report. J Int Med Res 2019;47:2679-86. [PMID: 30971156 DOI: 10.1177/0300060519839910] [Reference Citation Analysis]